Literature DB >> 28964706

The natural history of human papillomavirus infection.

Silvia de Sanjosé1, Maria Brotons2, Miguel Angel Pavón3.   

Abstract

Human papillomavirus (HPV) is a small double-stranded DNA virus that commonly infects humans. The oncogenic characteristics of HPV derive from the oncoproteins E6 and E7 that act inhibiting p53 and pRB tumor suppressors. About 5% of all cancers worldwide are attributable mainly to those known as high-risk, including HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. Infection with HPV is common after sexual initiation, but the majority of HPV infections do not cause symptoms or disease and are cleared within 12-24 months post-infection. Only a small fraction of those infections that persist or progress to a preneoplastic lesion result in cancer. Persistence of HPV infection is needed to start the oncogenic process. Clearance of infection is common in young adults. Viral load and viral type are the main cofactors for progression from infection to cervical intraepithelial lesions and cancer. Smoking, hormonal exposure, and HIV are additional exposures that increase the risk of progression to cancer. The adverse health effects of HPV infections can be largely controlled through vaccination and screening.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Acquisition; Cervical cancer; HPV; Natural history; Persistence; Risk factors

Mesh:

Year:  2017        PMID: 28964706     DOI: 10.1016/j.bpobgyn.2017.08.015

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  79 in total

1.  Directionality of Genital Human Papillomavirus Infection Transmission Within Heterosexual Couples: A Systematic Review and Meta-analysis.

Authors:  Rajshree Balaji; Aaron MacCosham; Khandideh Williams; Mariam El-Zein; Eduardo L Franco
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

2.  A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.

Authors:  Edison J Mavundza; Alison B Wiyeh; Phetole W Mahasha; Gregory Halle-Ekane; Charles S Wiysonge
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

3.  Human papillomavirus vaccine: Urgent need to promote gender parity.

Authors:  Cédric Abat; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2018-02-28       Impact factor: 8.082

4.  The Male Voice: A Qualitative Assessment of Young Men's Communication Preferences About HPV and 9vHPV.

Authors:  Jennifer A Sledge; Claire E Jensen; Nancy J Cibulka; Martha Hoffman
Journal:  J Community Health       Date:  2019-10

5.  Association Between Common Vaginal Infections and Cervical Non-Human Papillomavirus (HPV) 16/18 Infection in HPV-Vaccinated Women.

Authors:  Shang-Ying Hu; Sabrina H Tsang; Feng Chen; Qin-Jing Pan; Wen-Hua Zhang; Ying Hong; Joshua N Sampson; Allan Hildesheim; Fang-Hui Zhao; Aimée R Kreimer
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

6.  Voltammetric determination of human papillomavirus 16 DNA by using interdigitated electrodes modified with titanium dioxide nanoparticles.

Authors:  Nor A Parmin; Uda Hashim; Subash C B Gopinath; Sharipah Nadzirah; Zulida Rejali; Amilia Afzan; M N A Uda; V C Hong; R D A A Rajapaksha
Journal:  Mikrochim Acta       Date:  2019-05-08       Impact factor: 5.833

7.  Connaissances, utilisation et obstacles liés au dépistage du cancer du col utérin dans des hôpitaux de district de Kigali, au Rwanda.

Authors:  Gaudence Niyonsenga; Darius Gishoma; Ruth Sego; Marie Goretti Uwayezu; Bellancille Nikuze; Margaret Fitch; Pierre Céléstin Igiraneza
Journal:  Can Oncol Nurs J       Date:  2021-07-01

8.  Knowledge, utilization and barriers of cervical cancer screening among women attending selected district hospitals in Kigali - Rwanda.

Authors:  Gaudence Niyonsenga; Darius Gishoma; Ruth Sego; Marie Goretti Uwayezu; Bellancille Nikuze; Margaret Fitch; Pierre Céléstin Igiraneza
Journal:  Can Oncol Nurs J       Date:  2021-07-01

9.  Racial differences in HPV type 16 prevalence in women with ASCUS of the uterine cervix.

Authors:  Carolann Risley; Megan A Clarke; Kim R Geisinger; Mary W Stewart; Lei Zhang; Kim W Hoover; Laree M Hiser; Kenyata Owens; Maria DeMarco; Mark Schiffman; Nicolas Wentzensen
Journal:  Cancer Cytopathol       Date:  2020-04-03       Impact factor: 5.284

10.  Risk Factors for Non-Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA-Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial.

Authors:  Mónica S Sierra; Sabrina H Tsang; Shangying Hu; Carolina Porras; Rolando Herrero; Aimée R Kreimer; John Schussler; Joseph Boland; Sarah Wagner; Bernal Cortes; Ana C Rodríguez; Wim Quint; Leen-Jan van Doorn; Mark Schiffman; Joshua N Sampson; Allan Hildesheim
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.